Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus

Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus

Abstract Background Metformin is a first-line drug in type 2 diabetes mellitus (T2DM) treatment, yet whether metformin may increase all-cause or cardiovascular mortality of T2DM patients remains inconclusive. Methods We searched PubMed and Embase for data extracted from inception to July 14, 2020, w...

Full description

Bibliographic Details
Main Authors: Tian Li, Rui Providencia, Nan Mu, Yue Yin, Mai Chen, Yishi Wang, Manling Liu, Lu Yu, Chunhu Gu, Heng Ma
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Cardiovascular Diabetology
Subjects:
Metformin
Type 2 diabetes mellitus
Mortality
Cardiovascular diseases
Myocardial ischemia
Microvascular events
Online Access:https://doi.org/10.1186/s12933-020-01202-5

Internet

https://doi.org/10.1186/s12933-020-01202-5

Similar Items